| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.82 |
| The Vanguard Group, Inc. | 8.92 |
| Vanguard Group, Inc. (Subfiler) | 8.66 |
| State Street Corp. | 5.40 |
| Vanguard Total Stock Market Index Fund | 2.95 |
| BlackRock Fund Advisors | 2.63 |
| Vanguard 500 Index Fund | 2.21 |
| BlackRock Institutional Trust Co. NA | 2.20 |
| Geode Capital Management LLC | 1.71 |
| Northern Trust Corp. | 1.29 |
| Wellington Management Co. LLP | 1.25 |
| State Farm Investment Management Corp. | 1.20 |
| SPDR S&P 500 ETF Trust | 1.09 |
| Fidelity 500 Index Fund | 1.05 |
| Blackrock Group Ltd. (Subfiler) | 0.93 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 134'000 | 135'100 | 132'200 | 134'500 | 141'700 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.57 | 0.60 | 0.62 | 0.61 | 0.66 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 43'088 | 46'033 | 45'274 | 51'237 | 60'979 |
| Summe Anlagevermögen | 94'741 | 90'232 | 88'152 | 99'644 | 108'774 |
| Summe Aktiva | 157'303 | 152'954 | 157'728 | 174'894 | 182'018 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 34'581 | 30'480 | 28'681 | 36'366 | 34'751 |
| Summe Fremdkapital | 97'143 | 93'202 | 98'257 | 111'616 | 107'995 |
| Summe Eigenkapital | 60'160 | 59'752 | 59'471 | 63'278 | 74'023 |
| Summe Passiva | 157'303 | 152'954 | 157'728 | 174'894 | 182'018 |
Adresse
| One Johnson & Johnson Plaza, 08933 New Brunswick | |
| Telefon | +1 (732) 524-0400 |
| URL | http://www.jnj.com |
Management
|
A. Eugene Washington
Independent Director |
|
Alex Gorsky
Executive Chairman |
|
Alice Fabiano
Director-Corporate Contributions |
|
Anne M. Mulcahy
Lead Independent Director |
|
Ashley A. McEvoy
Executive VP & Worldwide Chairman-MedTech |
|
D. Scott Davis
Independent Director |
|
Dan Zelem
Chief Technology Officer |
|
Darius Adamczyk
Independent Director |
|
Frederic H. Moll
Chief Development Officer |
|
Hubert Joly
Independent Director |
|
Ian Edward Lamert Davis
Independent Non-Executive Director |
|
James D. Swanson
Global Chief Information Officer & Executive VP |
|
Jennifer A. Doudna
Independent Director |
|
Jennifer Taubert
EVP & Worldwide Chairman-Pharmaceuticals |
|
Jessica Moore
Vice President-Investor Relations |
|
Joaquin Duato
Chief Executive Officer & Director |
|
Jonathan Sheh
Director-Workplace Experience |
|
Joseph J. Wolk
Chief Financial Officer & Executive Vice President |
|
Kathleen M. Widmer
Group Chairman-Consumer North America |
|
Kathryn E. Wengel
Chief Global Supply Chain Officer & Executive VP |
|
Lisa Romanko
Senior Director-Investor Relations |
|
Marillyn A. Hewson
Independent Director |
|
Mark Alan Weinberger
Independent Director |
|
Mark B. McClellan
Independent Director |
|
Mary C. Beckerle
Independent Director |
|
Matthew Orlando
Secretary |
|
Matthew Stuckley
Senior Finance Director |
|
Michael Bzdak
Global Dir-Employee Engagement-Global Cmnty Impact |
|
Michael H. Ullmann
Executive Vice President & General Counsel |
|
Nadja Y. West
Independent Director |
|
Neil Ackerman
Head-Innovation, Global Supply & Transformation |
|
Paul Ruh
Chief Financial Officer-Consumer Health |
|
Peter M. Fasolo
Chief Human Resources Officer & Executive VP |
|
Peter Shen
Global Head-Research & Development |
|
Robert J. Decker
Chief Accounting Officer & Controller |
|
Ronald A. Kapusta
Chief Accounting Officer & Controller |
|
Scott White
Company Group Chairman |
|
Stuart McGuigan
Chief Information Officer |
|
Susan Can
Senior Director-Corporate Equity & Partnerships |
|
Thibaut Mongon
Executive Vice President |
|
Thomas J. Spellman
Secretary |
|
Vanessa A. Broadhurst
Executive Vice President-Global Corporate Affairs |
|
William E. Cohn
Vice President-Medical Devices |